Raras
Buscar doenças, sintomas, genes...
Síndrome de atrofia óptica-transtorno do desenvolvimento intelectual
ORPHA:401777CID-10 · H47.2CID-11 · 9C40.B0OMIM 615722DOENÇA RARA

A Síndrome de Atrofia Óptica e Deficiência Intelectual é uma condição rara e hereditária (passada de pais para filhos), que causa deficiência intelectual. Ela se caracteriza por atraso no desenvolvimento, deficiência intelectual e problemas sérios de visão, que podem ser causados por atrofia (enfraquecimento) do nervo óptico, hipoplasia (quando o nervo óptico não se forma completamente) ou por dificuldades do cérebro em processar o que se vê (deficiência visual cerebral). Outros sinais e sintomas comuns incluem fraqueza muscular, dificuldade para controlar os movimentos da boca e da língua (que afeta a fala e a alimentação), convulsões, transtorno do espectro autista e comportamentos repetitivos. As características faciais diferentes do comum são variadas e não exclusivas dessa síndrome.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

A Síndrome de Atrofia Óptica e Deficiência Intelectual é uma condição rara e hereditária (passada de pais para filhos), que causa deficiência intelectual. Ela se caracteriza por atraso no desenvolvimento, deficiência intelectual e problemas sérios de visão, que podem ser causados por atrofia (enfraquecimento) do nervo óptico, hipoplasia (quando o nervo óptico não se forma completamente) ou por dificuldades do cérebro em processar o que se vê (deficiência visual cerebral). Outros sinais e sintomas comuns incluem fraqueza muscular, dificuldade para controlar os movimentos da boca e da língua (que afeta a fala e a alimentação), convulsões, transtorno do espectro autista e comportamentos repetitivos. As características faciais diferentes do comum são variadas e não exclusivas dessa síndrome.

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
<1 / 1 000 000
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
0.0
Worldwide
Casos conhecidos
6
pacientes catalogados
Início
Neonatal
🏥
SUS: Cobertura mínimaScore: 20%
Centros em: PA, PR, RS, ES, RJ +5CID-10: H47.2
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

👁️
Olhos
10 sintomas
🧠
Neurológico
10 sintomas
😀
Face
7 sintomas
🦴
Ossos e articulações
5 sintomas
👂
Ouvidos
3 sintomas
🧬
Pele e cabelo
1 sintomas

+ 15 sintomas em outras categorias

Características mais comuns

100%prev.
Deficiência intelectual
Frequente (79-30%)
100%prev.
Acuidade visual reduzida
Frequente (79-30%)
100%prev.
Estrabismo
Ocasional (29-5%)
95%prev.
Atraso global do desenvolvimento
Frequente (79-30%)
83%prev.
Palidez do disco óptico
Frequência: 5/6
83%prev.
Deficiência visual cerebral
Ocasional (29-5%)
52sintomas
Muito frequente (6)
Frequente (10)
Ocasional (28)
Muito raro (7)
Sem dados (1)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 52 características clínicas mais associadas, ordenadas por frequência.

Deficiência intelectualIntellectual disability
Frequente (79-30%)100%
Acuidade visual reduzidaReduced visual acuity
Frequente (79-30%)100%
EstrabismoStrabismus
Ocasional (29-5%)100%
Atraso global do desenvolvimentoGlobal developmental delay
Frequente (79-30%)95%
Palidez do disco ópticoOptic disc pallor
Frequência: 5/683%

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Últimos 10 anos200publicações
Pico2025136 papers
Linha do tempo
2026Hoje · 2026🧪 2009Primeiro ensaio clínico📈 2025Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

1 gene identificado com associação a esta condição. Padrão de herança: Autosomal dominant.

NR2F1COUP transcription factor 1Disease-causing germline mutation(s) (loss of function) inAltamente restrito
FUNÇÃO

Coup (chicken ovalbumin upstream promoter) transcription factor binds to the ovalbumin promoter and, in conjunction with another protein (S300-II) stimulates initiation of transcription. Binds to both direct repeats and palindromes of the 5'-AGGTCA-3' motif. Represses transcriptional activity of LHCG

LOCALIZAÇÃO

Nucleus

VIAS BIOLÓGICAS (1)
Nuclear Receptor transcription pathway
MECANISMO DE DOENÇA

Bosch-Boonstra-Schaaf optic atrophy syndrome

An autosomal dominant disorder characterized by optic atrophy associated with developmental delay and intellectual disability. Most patients also have evidence of cerebral visual impairment.

EXPRESSÃO TECIDUAL(Ubíquo)
Fallopian Tube
139.3 TPM
Cervix Endocervix
119.7 TPM
Cervix Ectocervix
102.3 TPM
Ovário
93.0 TPM
Cerebelo
83.0 TPM
OUTRAS DOENÇAS (1)
Bosch-Boonstra-Schaaf optic atrophy syndrome
HGNC:7975UniProt:P10589

Variantes genéticas (ClinVar)

216 variantes patogênicas registradas no ClinVar.

🧬 NR2F1: NM_005654.6(NR2F1):c.116A>C (p.Glu39Ala) ()
🧬 NR2F1: NM_005654.6(NR2F1):c.609C>A (p.Tyr203Ter) ()
🧬 NR2F1: NM_005654.6(NR2F1):c.434_444del (p.Lys145fs) ()
🧬 NR2F1: NM_005654.6(NR2F1):c.61G>C (p.Gly21Arg) ()
🧬 NR2F1: GRCh38/hg38 5q14.3-21.2(chr5:90079852-103658165)x1 ()
Ver todas no ClinVar

Vias biológicas (Reactome)

1 via biológica associada aos genes desta condição.

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
·Pré-clínico5
Medicamentos catalogadosEnsaios clínicos· 0 medicamentos · 5 ensaios
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Síndrome de atrofia óptica-transtorno do desenvolvimento intelectual

Centros de Referência SUS

13 centros habilitados pelo SUS para Síndrome de atrofia óptica-transtorno do desenvolvimento intelectual

Centros para Síndrome de atrofia óptica-transtorno do desenvolvimento intelectual

Detalhes dos centros

Hospital Infantil Albert Sabin

R. Tertuliano Sales, 544 - Vila União, Fortaleza - CE, 60410-794 · CNES 2407876

Serviço de Referência

Rota
Anomalias CongênitasDeficiência Intelectual

Hospital de Apoio de Brasília (HAB)

AENW 3 Lote A Setor Noroeste - Plano Piloto, Brasília - DF, 70684-831 · CNES 0010456

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Estadual Infantil e Maternidade Alzir Bernardino Alves (HIABA)

Av. Min. Salgado Filho, 918 - Soteco, Vila Velha - ES, 29106-010 · CNES 6631207

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital das Clínicas da UFMG

Av. Prof. Alfredo Balena, 110 - Santa Efigênia, Belo Horizonte - MG, 30130-100 · CNES 2280167

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Universitário João de Barros Barreto

R. dos Mundurucus, 4487 - Guamá, Belém - PA, 66073-000 · CNES 2337878

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Instituto de Medicina Integral Prof. Fernando Figueira (IMIP)

R. dos Coelhos, 300 - Boa Vista, Recife - PE, 50070-902 · CNES 0000647

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Pequeno Príncipe

R. Des. Motta, 1070 - Água Verde, Curitiba - PR, 80250-060 · CNES 3143805

Serviço de Referência

Rota
Anomalias CongênitasDeficiência Intelectual

Hospital de Clínicas da UFPR

R. Gen. Carneiro, 181 - Alto da Glória, Curitiba - PR, 80060-900 · CNES 2364980

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Instituto Nacional de Saúde da Mulher, da Criança e do Adolescente Fernandes Figueira (IFF/Fiocruz)

Av. Rui Barbosa, 716 - Flamengo, Rio de Janeiro - RJ, 22250-020 · CNES 2269988

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital de Clínicas de Porto Alegre (HCPA)

Rua Ramiro Barcelos, 2350 Bloco A - Av. Protásio Alves, 211 - Bloco B e C - Santa Cecília, Porto Alegre - RS, 90035-903 · CNES 2237601

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital das Clínicas da FMUSP

R. Dr. Ovídio Pires de Campos, 225 - Cerqueira César, São Paulo - SP, 05403-010 · CNES 2077485

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital de Clínicas da UNICAMP

R. Vital Brasil, 251 - Cidade Universitária, Campinas - SP, 13083-888 · CNES 2748223

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital de Clínicas de Ribeirão Preto (HCRP-USP)

R. Ten. Catão Roxo, 3900 - Vila Monte Alegre, Ribeirão Preto - SP, 14015-010 · CNES 2082187

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual
Sobre os centros SUS: Estes centros são habilitados pelo Ministério da Saúde como Serviços de Referência em Doenças Raras ou Serviços de Atenção Especializada. O atendimento é pelo SUS, com encaminhamento da rede de atenção básica.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

🟢 Recrutando agora

3 pesquisas recrutando participantes. Converse com seu médico sobre a possibilidade de participar.

Outros ensaios clínicos

0 ensaios clínicos encontrados.

Distribuição por fase
Ver todos no ClinicalTrials.gov
🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

📖Melhor nível de evidência: Revisão
Timeline de publicações
0 papers (10 anos)
#1

Recessive Loss of DIAPH1 Function Causes a Progressive Neurodevelopmental Syndrome with Variable Immunological Involvement.

Genetics in medicine : official journal of the American College of Medical Genetics2026 Mar 16

Biallelic DIAPH1 pathogenic variants cause a neurodevelopmental syndrome occasionally associated with immunodeficiency. This study aims to define the clinical and immunological spectrum of DIAPH1-related neuroimmunological syndrome and explore the gene's developmental role using vertebrate models. 53 individuals with biallelic DIAPH1 variants, including 33 previously unreported patients were studied. Clinical features were analysed and functional studies were conducted using knockout models in Danio rerio and Xenopus tropicalis. Clinical features included developmental delay, intellectual disability, progressive microcephaly, cortical visual impairment or blindness, epilepsy, and frequent occipital-predominant brain abnormalities. Almost half suffered from infections, mainly affecting their respiratory tract related to epilepsy and aspiration. Although the majority had normal lymphocyte subsets and serum immunoglobulins, T-cell receptor excision circles and naïve T-lymphocyte counts were consistently low. The Xenopus model mirrored growth and eye defects seen in humans, while zebrafish exhibited no overt malformations but showed seizure-like behaviour in Phenothiazine assays. DIAPH1 is critical for neurodevelopment, immune regulation, and DNA repair. The DNA repair defect may influence susceptibility to infection, lymphoma, or treatment-related toxicity. Although absolute T-cell numbers are not consistent with SCID, impaired T-cell maturation suggests these patients could be identified by TREC newborn screening before neurological symptoms develop.

#2

Znhit3 regulates p53/p21 signaling and governs cerebellar granule cell development.

Cell death and differentiation2026 Mar 19

Mutations in ZNHIT3 are strongly associated with progressive encephalopathy with edema, hypsarrhythmia and optic atrophy (PEHO syndrome), characterized by severe cerebellar atrophy and profound intellectual disability; however, their role in cerebellar development remains unknown. By developing spatiotemporally-regulated conditional Znhit3 knockout mice, we discovered that Znhit3 is essential for granule cell progenitor survival, proliferation, differentiation, and migration. Knockout of Znhit3 caused loss of granule cell progenitors due to apoptosis, premature cell-cycle exit, and migration arrest and resulted in progressive anterior-lobe atrophy and motor deficits. The granule cell progenitor-autonomous defects secondarily impaired Purkinje cell alignment, dendritic maturation, and synaptic organization. Transcriptomic analyses revealed activation of the p53/p21 pathway, rRNA processing defects, and nucleolar stress. Genetic or pharmacologic inhibition of p53/p21 signaling rescued granule cell progenitor development and restored cerebellar architecture in the Znhit3-knockout mice. Thus, ZNHIT3 is a critical regulator of ribosome biogenesis and cerebellar growth, suggesting nucleolar stress-p53/p21 signaling as a potential therapeutic target in ZNHIT3-related disorders.

#3

Clinical, Neuroimaging and Video Electroencephalography Findings in Children With Congenital Zika Syndrome: An Analysis From a Neurorehabilitation Centre.

International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience2026 Apr

Congenital Zika syndrome (CZS) represents a spectrum of fetal and neonatal abnormalities resulting from in utero Zika virus (ZIKV) transmission during pregnancy. Given the severe multisystem disabilities, relative recency of the epidemic and limited long-term data, comprehensive characterization at specialized centres is crucial. This study aimed to examine clinical symptoms, brain imaging and brain activity (video electroencephalography, VEEG) patterns in children with CZS receiving care at a specialized rehabilitation centre. We conducted a cross-sectional study from August 2018 to January 2019 with 48 children diagnosed with CZS according to the Brazilian Ministry of Health criteria. We collected clinical data from electronic medical records. The most common clinical problems included bladder and bowel incontinence (97.9%), epilepsy (85.5%), facial abnormalities (89%), swallowing difficulties (83.3%), excessive irritability (81.3%), eye misalignment (75%), sleep problems (72.9%), acid reflux (62.0%) and vision problems (62.5%). Brain imaging revealed reduced brain tissue volume (95.8%), abnormal corpus callosum (91.1%), enlarged fluid-filled spaces in the brain (89.5%), calcium deposits at the brain's outer layers (78.3%) and abnormally thick brain folds (71.1%). We found significant links between bone/muscle malformations and both white matter disease (p = 0.036) and enlarged brain ventricles (p = 0.031). Children with CZS consistently show motor difficulties, multiple clinical problems and characteristic brain abnormalities. These findings predict significant limitations in daily activities, movement and cognitive-social development.

#4

Generation of BBSOAS patient-specific induced pluripotent stem cell lines harboring six NR2F1 pathogenic variants.

Stem cell research2026 Mar 10

Bosch-Boonstra-Schaaf Optic Atrophy Syndrome (BBSOAS) is a rare autosomal dominant neurodevelopmental disorder caused by mutations or deletions in NR2F1, leading to intellectual disability, developmental delay, visual impairments, epilepsy, hypotonia, and autistic traits. We generated six novel human induced pluripotent stem cell (hiPSC) lines from BBSOAS patients with variable clinical phenotypes. These lines provide a versatile and renewable resource by serving as a unique platform to model NR2F1-related developmental defects in vitro and elucidate the molecular and cellular mechanisms underlying BBSOAS. Their availability will facilitate mechanistic, comparative, and therapeutic studies, advancing our understanding of NR2F1 function in human neural development. PTS-related tetrahydrobiopterin deficiency (PTPSD) results in a lack of tetrahydropterin, an important cofactor for phenylalanine hydroxylase (PAH), tyrosine hydroxylase, and tryptophan hydroxylase. Deficiency can thus lead to neurotransmitter and neuropsychiatric disorders. The clinical spectrum of PTPSD is broad and differs according to age of onset, severity of disease, and whether preventative therapies were initiated and maintained from an early age. In the severe form, clinical symptoms may become apparent in the neonatal period and can include hypotonia, movement disorders, abnormal eye movements, autonomic dysregulation, and impaired development. Without treatment, developmental delays become more marked. Neurologic symptoms (dysarthria, dystonia, tremors, abnormal gait, parkinsonism, oculogyric crises, motor tics) may be ameliorated by treatment with sapropterin dihydrochloride and neurotransmitter precursors. Other features of the condition can include psychiatric comorbidities (ADHD, anxiety, depression), infant feeding difficulties leading to early growth failure, hyperprolactinemia, growth hormone deficiency, sleep issues, and autonomic dysfunction; many of these features can be ameliorated by appropriate treatment. In treated individuals, development often improves during adolescence, with many adults having a normal IQ level. In the mild (peripheral) form, affected individuals are usually asymptomatic apart from an increase in phenylalanine (Phe) levels. Some remain asymptomatic. However, with time, some have mild developmental delays and can develop deficiency of neurotransmitter production, such that treatment of some asymptomatic individuals may be required. The biochemical diagnosis of PTPSD is established in a proband with confirmed hyperphenylalaninemia, elevated neopterin levels, reduced biopterin levels, and a decreased biopterin-to-neopterin ratio in urine or dried blood spots (DBS) and normal dihydropteridine reductase (DHPR) activity in DBS. The molecular diagnosis of PTPSD is established in a proband by identification of biallelic pathogenic (or likely pathogenic) variants in PTS by molecular genetic testing. Targeted therapies: Immediate therapy with sapropterin (tetrahydrobiopterin dihydrochloride; BH4), a cofactor/cosubstrate of PAH, is recommended to reduce blood Phe concentrations in individuals with hyperphenylalaninemia. If sapropterin is not available, dietary Phe restriction should be implemented. Because sapropterin has limited access to the central nervous system (CNS), or rather, this access is only achieved at high doses, therapy with sapropterin does not normalize the activity of tyrosine or tryptophan hydroxylase in people with PTPSD. Additional treatment strategies are necessary for long-term management and may include the use of neurotransmitter precursors (levodopa plus decarboxylase inhibitor (DCI), i.e., carbidopa or benserazide), 5-hydroxytryptophan, and/or dopamine (rotigotine patch, pramipexole) and/or serotonin agonists, or other medications (MAO inhibitors such as selegiline) to address specific neurotransmitter deficiencies and maintain optimal neurologic function. Supportive care: Optimization of dosage and intervals of levodopa/DCI in those with abnormal movements/parkinsonism; growth hormone supplementation and/or optimization of neurotransmitter precursor therapy for growth hormone deficiency; optimization of neurotransmitter precursor therapy for recurrent hyperthermia; anticholinergic treatment may be considered for hypersalivation; standard treatment for developmental delay, spasticity, epilepsy, sleep disorders, and decreased bone mineral density. Biochemical surveillance: Routine Phe monitoring in infants (age <1 year) weekly until normalized and then every three to six months once levels normalize; every six months in children younger than age 12 years; and every six to 12 months in adolescents and adults; the Phe target ranges correspond to those of PAH deficiency. Prolactin level at each visit. Routine clinical visits with a metabolic specialist (and metabolic dietician if on Phe-restricted diet) every one to three months in infants (age <1 year), every three to six months between ages one and seven years, and every six to 12 months in those age eight years and older. General surveillance: At each visit, measure growth parameters and evaluate nutritional status; asses for new neurologic manifestations (changes in tone, seizures, movement disorders); monitor developmental progress and assess educational needs; monitor for behavioral issues (anxiety, ADHD, emotional dysregulation, depression, aggression); and assess for signs and symptoms of sleep disorders. At ages two, six, 12, and 18 years, consider neuropsychological evaluation. In adulthood, periodic parathormone levels and DXA scan. As needed, consider EEG to differentiate from movement disorder seizures. Agents/circumstances to avoid: Persons with PTPSD on Phe-reduced diet should either avoid products containing aspartame or calculate total intake of Phe when using such products and adapt diet components accordingly. Evaluation of relatives at risk: If prenatal genetic testing has not been performed, each at-risk newborn sib should be evaluated immediately (at or just after 24 hours) after birth for PTPSD using measurement of blood Phe concentration to allow for earliest possible diagnosis and treatment. If older sibs have not undergone NBS or genetic testing for the known familial pathogenic variants in PTS, measure blood Phe concentrations to clarify their disease status. Pregnancy management: Women with PTPSD who have received appropriate treatment throughout childhood and adolescence and during pregnancy may have offspring with normal intellectual and behavioral development, particularly if levels of Phe are kept in the normal range during pregnancy. Intensive clinical and biochemical supervision by a multidisciplinary team before, during, and after pregnancy in a woman with PTPSD is essential to control the symptoms of the disease, adjust the treatment if needed, and monitor the development of the fetus. If the affected woman has elevated blood Phe concentrations during pregnancy, the fetus is at high risk for maternal phenylketonuria (MPKU) syndrome (reported specifically in women who have PAH deficiency as the primary cause of their elevated Phe levels), including malformations and intellectual disability, since Phe is a potent teratogen. PTPSD is inherited in an autosomal recessive manner. If both parents are known to be heterozygous for a PTS pathogenic variant, each sib of an affected individual has at conception a 25% chance of being affected, a 50% chance of being an asymptomatic carrier, and a 25% chance of inheriting neither of the familial PTS pathogenic variants. Children born of one parent with PTPSD and one parent with two normal PTS alleles are obligate heterozygotes. If the mother is the affected parent, MPKU syndrome is a critical issue. Females with PTPSD should receive counseling regarding the teratogenic effects of elevated maternal plasma Phe concentration (i.e., MPKU syndrome) when they reach childbearing age. Once the PTS pathogenic variants have been identified in an affected family member, carrier testing for at-risk relatives and prenatal/preimplantation genetic testing for PTPSD are possible.

#5

Sleep-Disordered Breathing in Chung-Jansen Syndrome.

International journal of molecular sciences2026 Feb 11

We report a thirty-six-year-old woman with intellectual disability who was referred for evaluation of suspected obstructive sleep apnea. The initial clinical impression suggested a syndromic case, so comprehensive genetic testing was undertaken. Overnight polysomnography revealed a severe rapid eye movement-predominant obstructive sleep apnea syndrome with an apnea-hypopnea index of 31.9 events per hour, rapid eye movement apnea-hypopnea index of 113.8 events per hour, and lowest oxygen saturation of 66%. Treatment with continuous positive airway pressure improved respiratory and sleep quality indices and was well tolerated. Whole-exome sequencing identified a de novo splice site variant in the pleckstrin homology domain interacting protein gene (c.41-1G > A), confirming a molecular diagnosis of Chung-Jansen Syndrome. Chung-Jansen syndrome is a rare neurodevelopmental disorder caused by heterozygous pathogenic variants in the pleckstrin homology domain interacting protein gene, marked by developmental delay, intellectual disability, behavioral abnormalities, dysmorphism, and progressive obesity. PHIP influences central and peripheral pathways controlling satiety, pancreatic function, and body weight. Despite frequent reports of sleep problems, systematic evaluation of sleep-disordered breathing has been limited. This adult case provides the first polysomnographic confirmation in the syndrome, supporting proactive screening for obstructive sleep apnea-especially in those with obesity. Integrating genetic assessment into sleep care can reduce diagnostic delays and better guide therapy and prognosis.

Publicações recentes

Ver todas no PubMed

📚 EuropePMCmostrando 199

2026

Recessive Loss of DIAPH1 Function Causes a Progressive Neurodevelopmental Syndrome with Variable Immunological Involvement.

Genetics in medicine : official journal of the American College of Medical Genetics
2026

Znhit3 regulates p53/p21 signaling and governs cerebellar granule cell development.

Cell death and differentiation
2026

Clinical, Neuroimaging and Video Electroencephalography Findings in Children With Congenital Zika Syndrome: An Analysis From a Neurorehabilitation Centre.

International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience
2026

Intensive lipid-lowering therapy-related regression of a vulnerable plaque confirmed by serial optical coherence tomography: a case report.

Frontiers in cardiovascular medicine
2026

Generation of BBSOAS patient-specific induced pluripotent stem cell lines harboring six NR2F1 pathogenic variants.

Stem cell research
2026

Sleep-Disordered Breathing in Chung-Jansen Syndrome.

International journal of molecular sciences
2026

From the Optic Neuritis Treatment Trial to Antibody-Mediated Optic Neuritis: Four Decades of Progress and Unanswered Questions.

Biomedicines
2026

Congenital core myopathy linked to SOX5: Expanding the phenotypical spectrum of Lamb-Shaffer syndrome.

Journal of neuromuscular diseases
2026

Prenatal Diagnosis and Neurodevelopmental Outcome of Children With Marked Opening of the Fourth Ventricle: Challenges and Pitfalls in MRI Diagnostic Criteria.

Prenatal diagnosis
2026

Bi-allelic variants in FSD1L cause a neurodevelopmental disorder overlapping with L1 syndrome.

American journal of human genetics
2026

Pain in multiple sclerosis: clinical phenotypes and therapeutic strategies - a narrative review.

Pain reports
2026

Clinical features and management of 16q24.3 microdeletion KBG syndrome: literature review.

Frontiers in pediatrics
2026

In vivo base editing of Chd3 rescues behavioural abnormalities in mice.

Nature
2026

Spindle density relates to cognitive outcomes in infantile epileptic spasms syndrome with unknown etiology: A retrospective cohort study.

Epilepsia
2026

Prevalence and Patterns of Cranial Nerve Involvement in CIDP, Autoimmune Nodopathy, MMN, and Anti-MAG Neuropathy: A Multicenter Korea/UK Study of 582 Patients.

European journal of neurology
2026

Bi-allelic loss-of-function variants in JKAMP cause a neurodevelopmental syndrome associated with dysregulation of GPR37 trafficking.

American journal of human genetics
2026

First demyelinating attack in children: A twelve year single center cohort.

Multiple sclerosis and related disorders
2026

Pediatric neuromyelitis optica spectrum disorders in Dakar: Insights from a preliminary multicentric case series in Senegal.

Brain &amp; development
2026

Prenatal Diagnosis of a Feingold Syndrome Pregnancy Complicated with Severe Preeclampsia: A Report of a Challenging Case.

Genes
2026

Biallelic Rare COL18A1 Variants in Patients With Neurological Phenotypes Without Severe Ophthalmologic Abnormalities.

Pediatric neurology
2026

Immunotherapies for neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein antibody-associated disease.

Handbook of clinical neurology
2026

Proceedings of the 12th International Meeting on Neuroacanthocytosis, Cohen Syndrome, and Other VPS13-Related Disorders.

Tremor and other hyperkinetic movements (New York, N.Y.)
2026

Precision in Complexity: A Protocol-Driven Quantitative Anatomic Strategy for Giant Olfactory Groove Meningioma Resection in a High-Risk Geriatric Patient.

Diagnostics (Basel, Switzerland)
2026

Outcomes of Children With Optic Neuritis as Their First Demyelinating Event.

Journal of child neurology
2026

The Baraitser-Winter Cerebrofrontofacial Syndrome Recurrent R196H Variant in Cytoplasmic β-Actin Impairs Its Cellular Polymerization and Stability.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology
2026

Quantitative assessment of light discomfort thresholds in a patient with photoallodynia treated with topical naltrexone 0.01.

American journal of ophthalmology case reports
2025

An Atypical Female Case of Ichthyosis Follicularis, Alopecia, and Photophobia (IFAP) Syndrome with Severe Lower Limb Contractures Requiring Orthopedic Surgery.

Clinical, cosmetic and investigational dermatology
2026

Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD): Mechanisms, Syndromes, and Management.

International ophthalmology clinics
2025

A Case Report of PLXNA1-Related Dworschak-Punetha Neurodevelopmental Disorder With Pachygyria and Polymicrogyria.

American journal of medical genetics. Part A
2026

Wearable eye-tracking of visuomotor strategies in table tennis players of diverse expertise and cognitive function in a naturalistic environment.

Human movement science
2026

Fluoroquinolone-Associated Psychiatric and Ocular Adverse Events: A Disproportionality Analysis Using Real-World Data From FAERS (2011-2024).

Pharmacology research &amp; perspectives
2025

Novel KDM3B Variants in Two Chinese Patients With Global Developmental Delay and Autism.

International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience
2025

A new case of Rafiq syndrome with coexisting thyroid dyshormonogenesis type 6 in a Chinese patient: case report and literature review.

Frontiers in endocrinology
2025

Influence of gestational history on neural tube defects and Eisenmenger syndrome: associations with intellectual disability and visual impairment in children and adults - a systematic review.

Frontiers in pediatrics
2025

Anesthetic Management of a Patient With Myhre Syndrome.

Anesthesia progress
2025

Novel variant in PNPLA6 gene causes Oliver-McFarlane syndrome in a Chinese family: 13 years follow-up.

Frontiers in genetics
2025

Disease-Modifying Treatment Options in Very Early Onset Multiple Sclerosis-What Choices Are There for Onset Under 5 Years of Age? A Systematic Review.

Journal of clinical medicine
2026

Expanding the Phenotype of Syndromic SLC30A9 -Associated Disease.

American journal of medical genetics. Part A
2026

Macular and optic nerve hypoplasia in chromosome 2p partial trisomy.

Ophthalmic genetics
2025

Atypical Inter-Brain Synchrony and Social Communication Deficits in Girls with Fragile X Syndrome: Evidence from Functional Near-infrared Spectroscopy Hyperscanning.

Research square
2026

The Developmental Landscape of Children With Uveal Coloboma and Its Relationship With Clinical Phenotype and Genetics.

American journal of ophthalmology
2025

WDR81 Mutation in Two Siblings: A Case Report and Review of Literature.

Molecular syndromology
2025

Bilateral Testicular Regression Syndrome and Optic Nerve Atrophy: Clinical Aspects of a Child with a <italic>SEMA3E</italic> Loss-of-Function Variant.

Sexual development : genetics, molecular biology, evolution, endocrinology, embryology, and pathology of sex determination and differentiation
2025

Diagnostic odyssey of opsoclonus-myoclonus syndrome and barriers to early detection.

Brain &amp; development
2026

Nance-Horan Syndrome: Further Delineation of the Affected Male and the Female Carrier Phenotypes.

American journal of medical genetics. Part A
2025

Sudden Bilateral Vision Loss in A Young Patient with Systemic Autoimmune Disease and A Normal Brain MRI, which Responded to Steroid Treatment.

European journal of case reports in internal medicine
2026

Unraveling the relationship between childhood dry eye symptoms and sleep patterns.

Jornal de pediatria
2025

A novel frameshift variant in the MED13 gene causing intellectual developmental disorder-61 in a Chinese family.

Frontiers in pediatrics
2025

Novel variant causing OTUD6B-related syndrome with ocular dysplasia and hypothyroidism: the first Chinese case.

BMC pediatrics
2025

Optic nerve hypoplasia/dysplasia in Coffin-Siris syndrome: a case series.

Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus
2025

Accumulation of complex I assembly intermediates in a novel presentation of RTN4IP1-related disorder with developmental delay, ataxia and dyskinesia.

Molecular genetics and metabolism
2025

Burden of ophthalmologic disorders in obstructive sleep apnea.

Respiratory medicine
2025

Neuroimaging Findings and Neurocognitive Features of Patients with Ochoa Syndrome (Urofacial Syndrome)-A Prospective Experimental Study.

Diagnostics (Basel, Switzerland)
2025

The burden of bacterial antimicrobial resistance in the WHO Eastern Mediterranean Region 1990-2021: a cross-country systematic analysis with forecasts to 2050.

The Lancet. Public health
2025

Outcomes of Maintenance Immunotherapy in a Cohort of Patients With Susac Syndrome: A 2-Center Large Case Series.

Neurology. Clinical practice
2025

Predictors of relapse and disability in NMOSD, MOGAD, and double-seronegative demyelinating syndromes: an international multicenter retrospective cohort study.

Journal of neurology
2025

Long-term real-world effectiveness and safety of fremanezumab in 1140 patients with migraine and at least 6 months of treatment: third interim analysis of the pan-European PEARL study.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
2025

Case 341: Infratentorial Posterior Reversible Encephalopathy Syndrome Associated with Interferon-β in Relapsing Multiple Sclerosis.

Radiology
2025

Adult genomic medicine: lessons from a multisite study of 2700 patients.

Genome medicine
2025

Purtscher-like retinopathy following mechanical thrombectomy: A case report.

SAGE open medical case reports
2025

Development of a Patient-Centered Outcome Tool for Blepharospasm: A Stepwise Modified Delphi Study.

Toxins
2025

Case Report: A case of traumatic subgaleal hematoma with delayed massive exophthalmos.

Frontiers in surgery
2025

Epilepsy due to a MED25 Homozygous Pathogenic Founder Variant.

Journal of child neurology
2025

Clinical Research for Inherited Retinal Disease Related Pediatric Blindness: A Preliminary Descriptive Analysis Based on ClinicalTrials.gov.

Journal of multidisciplinary healthcare
2025

Diagnosis of multiple sclerosis: 2024 revisions of the McDonald criteria.

The Lancet. Neurology
2025

Baló's concentric sclerosis: A retrospective case series.

Multiple sclerosis and related disorders
2025

Safety and Efficacy of Diquafosol Compared to Artificial Tears for the Treatment of Dry Eye: A Systematic Review and Meta-Analysis.

International journal of molecular sciences
2025

Genome sequencing provides high diagnostic yield and new etiological insights for intellectual disability and developmental delay.

NPJ genomic medicine
2025

Case Report: Identification of a novel hemizygous missense RPL10 gene variant in two unrelated patients.

Frontiers in pediatrics
2025

Models of Bosch-Boonstra-Schaaf optic atrophy syndrome reveal genotype-phenotype correlations in brain structure and behavior.

Disease models &amp; mechanisms
2025

Epigenetic Mechanisms in Neurofibromatosis Types 1 and 2.

Epigenomes
2025

A comparative study on clinico-radiological profile, treatment responses and outcomes of double seronegative NMOSD compared to AQP4-IgG positive NMOSD, and MOGAD.

Multiple sclerosis and related disorders
2025

Low Vision Rehabilitation in a Family Affected by Peters' Anomaly Syndrome.

Clinical optometry
2025

Multiple problems: a case of Cohen syndrome VPS13B mutation causing bilateral spherical lenses combined with retinitis pigmentosa.

BMC ophthalmology
2025

Challenges with shifting, regardless of disengagement: attention mechanisms and eye movements in Williams syndrome.

Journal of neurodevelopmental disorders
2026

Chronic Ocular Sequelae of Stevens-Johnson Syndrome: Recent Advances in Understanding of Patho-Physiology and Management.

Seminars in ophthalmology
2025

Prevalence and Potential Risk Factors of Ocular Disorders Among Institutionalised Adults With Intellectual Disabilities-A City-Wide Survey in Taipei City.

Journal of intellectual disability research : JIDR
2025

Prediction of apolipoprotein A-I and high-density lipoprotein cholesterol in the neurological impairment and relapse of neuromyelitis optica spectrum disorder.

Frontiers in neuroscience
2025

Korean medicine combination treatment for chronic tinnitus unresponsive to conventional treatment: A case report and review of literature.

World journal of clinical cases
2025

Cerebral/Cortical visual impairment (CVI) in Down syndrome: a case series.

Frontiers in human neuroscience
2025

Analysis of the Body Mass Index of Latino Patients With Bardet-Biedl Syndrome.

Cureus
2025

Complex strabismus in a patient with KBG syndrome with 16q24.3 microdeletion.

Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus
2025

Poretti-Boltshauser Syndrome: A Potential Pathognomonic "Wolfjaw" Pattern of Retinal Perfusion.

Ophthalmic surgery, lasers &amp; imaging retina
2026

Vestibular Assessment and Compensation in Unilateral Acute Vestibular Dysfunction: A Prospective Single-Armed Cohort Study of Vestibular Schwannoma After Surgery.

Neurosurgery
2025

Systematic phenotype and genotype characterization of Moebius syndrome.

Genetics in medicine open
2025

A Rare Case of Eight-and-a-Half Syndrome Due to a Pontine Ischemic Stroke.

Cureus
2025

NIR-II Luminescent Nanothermometer for Precise Assessment of Ischemic Stroke.

ACS applied materials &amp; interfaces
2025

A novel TIMM8A mutation in Mohr-Tranebjaerg syndrome without hearing loss and with basal ganglia iron deposition.

Orphanet journal of rare diseases
2025

A novel NR2F1-associated microdeletion underlying Bosch-Boonstra-Schaaf optic atrophy syndrome.

Ophthalmic genetics
2025

Full-Spectrum Medicinal Cannabis Plant Extract 0.08% THC (NTI164) Improves Symptoms of Rett Syndrome: An Open-Label Study.

Journal of paediatrics and child health
2025

Expansion of the Genotypic and Phenotypic Spectrum of TCTN3-Related Joubert Syndrome.

Genes
2025

Neuromyelitis Optica Spectrum disorder - Clinical profile, treatment and risk factors for relapse in three tertiary hospitals in South Africa. An observational study.

Journal of the neurological sciences
2025

Foveal hypoplasia in Myhre syndrome: a novel association.

Ophthalmic genetics
2025

Treating Glaucoma in Intellectually Disabled Patients: Novel Criteria for Choosing Surgical Candidates.

Journal of ophthalmology
2025

The feasibility of using eye-tracking technology for cognitive screening in Down syndrome with dementia: A cross-sectional case series.

Alzheimer's &amp; dementia : the journal of the Alzheimer's Association
2025

A Report of a Child with SEC31A-Related Neurodevelopmental Disorder.

International journal of molecular sciences
2025

CHD8 Variant and Rett Syndrome: Overlapping Phenotypes, Molecular Convergence, and Expanding the Genetic Spectrum.

Human mutation
2025

Translational insights from EAE models : decoding MOGAD pathogenesis and therapeutic innovation.

Frontiers in immunology
2025

Clinical Spectrum of Acquired Demyelinating Syndromes in Children: A Tertiary Hospital Experience.

Neurology and therapy
2025

French guidelines for the diagnosis and management of pure hereditary spastic paraplegia.

Revue neurologique
2025

A case series of joubert syndrome evaluated with whole exome sequencing and the utility of optical genome mapping in the diagnosis.

Neurogenetics
2025

Novel KMT2D pathogenic variant causing Kabuki Syndrome with associated macular abnormalities and retinopathy of prematurity.

Ophthalmic genetics
2025

Phenotypic Spectrum of KATNIP-Associated Joubert Syndrome: Possible Association with Esophageal Atresia and Review of the Literature.

Genes
2025

Senior-Loken Syndrome: Ocular Perspectives on Genetics, Pathogenesis, and Management.

Biomolecules
2025

Prevalence, Risk Factors, and Intervention of Long-Term Sleep Disturbance After Intensive Care Unit Discharge: A Scoping Review.

Cureus
2025

Typical presentation of autosomal recessive oculocutaneous albinism in two siblings.

GMS ophthalmology cases
2025

DYRK1A syndrome presenting with a familial exudative vitreoretinopathy (FEVR)-like retinovascular phenotype.

Ophthalmic genetics
2025

Report of Consensus Panel 1 from the 12th International Workshop on the management of patients with IgM and Waldenstrom's Macroglobulinemia related neuropathy.

Seminars in hematology
2025

Aphallia in a patient with 9q34 duplication syndrome: a case report.

BMC urology
2025

Cogan's syndrome. A comprehensive review.

European journal of internal medicine
2026

Understanding speech and language in KIF1A-associated neurological disorder.

European journal of human genetics : EJHG
2025

Ocular manifestations in pediatric tumor suppressor gene mutations: a case series and literature review of RB1, NF1, NF2, VHL, and TSC.

BMC pediatrics
2025

Long term follow-up of multiorgan disease in Kleefstra syndrome 2 in an adult - case report.

BMC neurology
2025

Cerebellar Ataxia-deafness-narcolepsy (ADCA) syndrome. Description of a variable family phenotype.

Acta neurologica Belgica
2025

Predictors of Recovering Full Consciousness: Results From a Prospective Multisite Italian Study.

European journal of neurology
2025

Clinical manifestations of dual-gene variants involving ABCA4 in retinal dystrophies.

BMC ophthalmology
2025

Clinical profile and treatment outcomes in acute retinal necrosis in a South Indian patient population.

Indian journal of ophthalmology
2025

Bi-allelic variants in BRF2 are associated with perinatal death and craniofacial anomalies.

Genome medicine
2025

RNA sequencing driven diagnosis expands the phenotypic spectrum of NBAS deficiency.

Molecular genetics and metabolism
2025

Diagnostic Utility of Next-Generation Sequencing-based CNV Analysis in Eleven Patients with Peters-Plus Syndrome: A Single-Center Experience.

Journal of clinical research in pediatric endocrinology
2025

Charles Bonnet syndrome among visually impaired military veterans: findings from a UK screening and survey study.

BMJ open ophthalmology
2025

Novel Compound Heterozygous Variants in ZNF526 Causing Dentici-Novelli Neurodevelopmental Syndrome: A Case Report and Literature Review.

Molecular genetics &amp; genomic medicine
2025

Optic atrophy in Lamb-Shaffer syndrome: two case presentations with ophthalmic imaging studies.

Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus
2025

Gaze behavior in infancy associates with developmental outcome at the age of two years in early-onset epilepsies.

Epilepsy &amp; behavior : E&amp;B
2025

Impact of communication modalities on autonomy and social participation of persons with locked-in syndrome.

Brain impairment : a multidisciplinary journal of the Australian Society for the Study of Brain Impairment
2025

The Ocular Manifestations of Individuals With Down Syndrome: A Systematic Review and Meta-Analysis.

Journal of ophthalmology
2025

Case report: ocular manifestations of NFIX-associated Malan syndrome.

Ophthalmic genetics
2025

Is a Benign Disease Course Possible in Untreated AQP4-IgG NMOSD?

European journal of neurology
2025

Gynecological issues in children and adolescents seen at rare-disease referral centers: an observational retrospective cohort study.

Orphanet journal of rare diseases
2024

Ocular Surface Disease Index questionnaire in different languages.

Medical hypothesis, discovery &amp; innovation ophthalmology journal
2025

Early White Matter Microstructure Alterations in Infants with Down Syndrome.

medRxiv : the preprint server for health sciences
2025

Natural history of patients with autosomal dominant WFS1 pathogenic variants associated with sensorineural hearing loss and optic atrophy.

medRxiv : the preprint server for health sciences
2025

[Clinical observation on the efficacy of ringheaded thumb-tack needle therapy combined with tuina and active functional exercise in the treatment of neck-type cervical spondylosis].

Zhen ci yan jiu = Acupuncture research
2025

[Clinical features of CHARGE syndrome in children].

[Zhonghua yan ke za zhi] Chinese journal of ophthalmology
2025

The Process of Diagnosing Xia Gibbs Syndrome in A Male Child with Autism Spectrum Disorder and AHDC1 Gene Mutation: Case Report.

Noro psikiyatri arsivi
2025

Management of anophthalmia, microphthalmia and coloboma in the newborn, shared care between neonatologist and ophthalmologist: a literature review.

Italian journal of pediatrics
2025

Malignant Peripheral Nerve Sheath Tumor (MPNST) Arising from Orbital Plexiform Neurofibroma in a Small Child With Neurofibromatosis Type 1.

Cancer diagnosis &amp; prognosis
2025

Facial characteristics description and classification based on 3D images of Fragile X syndrome in a retrospective cohort of young Chinese males.

Computers in biology and medicine
2025

A pathogenic NR2F1 gene variant disrupts transcriptional activity and causes severe neurodevelopmental delay in Bosch-Boonstra-Schaaf syndrome.

Hereditas
2025

A randomized crossover trial: The impact of ocular lubrication on migraine severity in persons with dry eye disease and migraine.

Optometry and vision science : official publication of the American Academy of Optometry
2025

The Arg99Gln Substitution in HNRNPC Is Associated with a Distinctive Clinical Phenotype Characterized by Facial Dysmorphism and Ocular and Cochlear Anomalies.

Genes
2025

Identification of a novel single nucleotide deletion in the NHS causing Nance-Horan syndrome.

BMC ophthalmology
2025

A Drosophila model for Costello Syndrome caused by Ras mutation K117R.

bioRxiv : the preprint server for biology
2025

The Natural Course of Bosch-Boonstra-Schaaf Optic Atrophy Syndrome.

Clinical genetics
2025

Autoantibody profile (MOG-IgG-positivity, AQP4-IgG-positivity, and double-seronegativity) as an outcome predictor after optic neuritis.

Clinical neurology and neurosurgery
2025

Strabismus in Genetic Syndromes: A Review.

Clinical &amp; experimental ophthalmology
2025

Kidins220-deficient hydrocephalus mice exhibit altered glial phenotypes and AQP4 differential regulation in the retina and optic nerve, with preserved retinal ganglion cell survival.

Fluids and barriers of the CNS
2025

Torpedo maculopathy in a patient with DeSanto-Shinawi syndrome.

European journal of ophthalmology
2025

Eye Tracking as a Tool for Detecting Alzheimer's Disease in People With Down Syndrome.

Journal of intellectual disability research : JIDR
2025

Poretti-Boltshauser Syndrome: A Report of Two Cases From Bahrain With a Novel Mutation and Literature Review.

Cureus
2025

Phenotypic Expansion of Knobloch Syndrome Type 2 in an Individual With a De Novo PAK2 Variant.

American journal of medical genetics. Part A
2025

TBC1D20 coordinates vesicle transport and actin remodeling to regulate ciliogenesis.

The Journal of cell biology
2025

Neurobehavioral Outcomes Relate to Activation Ratio in Female Carriers of Fragile X Syndrome Full Mutation: Two Pediatric Case Studies.

International journal of molecular sciences
2025

Effect of Different Treatments on Retinal Thickness Changes in Patients With Multiple Sclerosis: A Review.

CNS neuroscience &amp; therapeutics
2025

Balanced Translocation t(3;12) Disrupting HMGA2 and NAALADL2 Genes in Twins With Silver-Russell Syndrome and Intellectual Disability.

Clinical genetics
2025

Comprehensive assessment reveals numerous clinical and neurophysiological differences between MECP2-allelic disorders.

Annals of clinical and translational neurology
2025

SMAD4 Pathogenic Variants in Seven New Brazilian Individuals With Myhre Syndrome Including a New Family.

American journal of medical genetics. Part A
2025

DNA-binding affinity and specificity determine the phenotypic diversity in BCL11B-related disorders.

American journal of human genetics
2025

Biochemical and structural characterization of Rab3GAP reveals insights into Rab18 nucleotide exchange activity.

Nature communications
2025

Novel Phenotypes and Genotype-Phenotype Correlations in a Large Clinical Cohort of Patients With Kleefstra Syndrome.

Clinical genetics
2024

The Spectrum of Ocular Diseases in the Onchocerciasis-Endemic Focus of Raga in South Sudan.

Research and reports in tropical medicine
2024

Susac's Syndrome: A Tale of Disability Due to Late Recognition.

Cureus
2025

Short-term γ-aminobutyric acid antagonist treatment improves long-term sleep quality, memory, and decision-making in a Down syndrome mouse model.

Sleep
2024

Review of a specialist Rett syndrome clinic from 2003 to the COVID pandemic: clinic experience and carer perspectives.

Orphanet journal of rare diseases
2024

Structural variant allelic heterogeneity in MECP2 duplication syndrome provides insight into clinical severity and variability of disease expression.

Genome medicine
2025

Posterior Cortical Atrophy Due to Alzheimer Disease in a Person With Down Syndrome: A Case Report.

Neurology
2025

Brain microstructural damage through serial diffusion tensor imaging and outcomes in Susac syndrome: A prospective cohort study.

European journal of neurology
2025

Out-of-frame Translation Rescues a Loss-of-function Variant in a Novel TBCE Phenotype.

The Journal of clinical endocrinology and metabolism
2025

The correlation of intracranial parenchymal calcium score and the severity of neurological clinical presentation in carbonic anhydrase deficiency type 2.

Brain &amp; development
2025

Assessment of Affordances in the Home Environment and Neurodevelopment of Children With Congenital Zika Syndrome.

Child: care, health and development
2025

Protein-Variant-Phenotype Study of NBAS Using AlphaFold in the Aspect of SOPH Syndrome.

Proteins
2024

Ocular findings in Baraitser-Winter syndrome with a de novo mutation in the ACTG1 gene: a case report.

BMC ophthalmology
2025

Cardiovascular autonomic dysfunction and sleep abnormalities in children with Prader-Willi syndrome.

Clinical autonomic research : official journal of the Clinical Autonomic Research Society
2025

Surgical Treatment of Strabismus in Children With Developmental Delay: A Review of the Literature and Results of Personal Experience.

Journal of pediatric ophthalmology and strabismus
2024

New-Onset Multiple Sclerosis in Pregnancy: Diagnostic Approaches and Treatment Dilemmas.

Cureus
2025

Novel compound heterozygous P4HTM variants in a girl with developmental and epileptic encephalopathy: First case report of P4HTM variant-associated epileptic encephalopathy.

Seizure
2024

Small Complex Rearrangement in HINT1-Related Axonal Neuropathy.

Genes
2024

Clinical characteristics of patients with P4HTM variant-associated epilepsy and therapeutic exploration: a case report and literature review.

Frontiers in neurology
2024

Homonymous hemi-macular atrophy in multiple sclerosis.

Multiple sclerosis (Houndmills, Basingstoke, England)
2024

[Classic presentation of neuromyelitis optica: clinical case and review of the literature].

Revista medica del Instituto Mexicano del Seguro Social
2024

The DESSH Clinic: A New Multidisciplinary Clinic to Address the Complex Needs of Individuals with a Rare Genetic Disorder.

Missouri medicine
2024

A novel mutation in SMARCB1 associated with adult Coffin-Siris syndrome and meningioma.

Acta biochimica et biophysica Sinica
2026

BILATERAL MACULAR DYSPLASIA IN COFFIN-SIRIS SYNDROME.

Retinal cases &amp; brief reports
2025

Estimates and trends in the global burden of glaucoma influenced by metabolic risk factors from Global Burden of Disease Study between 1990 to 2019.

European journal of ophthalmology
2024

HLA-B*51:01 in Iranian patients with Behcet uveitis syndrome.

Reumatologia clinica
2025

Expanding the Genetic and Phenotypic Spectrum of Mowat-Wilson Syndrome: A Study of 10 Turkish Patients With an Intrafamilial Recurrence Caused by First Intragenic Large Deletion.

American journal of medical genetics. Part A
2025

Ring Chromosome 17 Syndrome-A Case Report and Discussion of Diagnostic Methods.

American journal of medical genetics. Part A
2024

[Viral uveitis in the tropics].

Journal francais d'ophtalmologie
2024

Homozygosity for a hypomorphic mutation in frizzled class receptor 5 causes syndromic ocular coloboma with microcornea in humans.

Human genetics
2024

Multimodal Assessment of the Origin of Myoclonus in Lance-Adams Syndrome.

Neurology
2024

Homozygous variants in WDR83OS lead to a neurodevelopmental disorder with hypercholanemia.

American journal of human genetics
2024

Rehabilitation and Physiotherapy Action Strategy for an Acute Case of Lateral Medullary Syndrome: A Case Report.

Cureus
2024

Association of LONP1 gene with epilepsy and the sub-regional effect.

Scientific reports
2024

New insights into the use of high dose corticosteroids and plasmapheresis in persons with MOGAD and NMOSD.

Multiple sclerosis and related disorders
2023

A Clinical Study on Severity of Dry Eye in Individuals with Pterygium at a Tertiary Hospital in South Kerala.

Middle East African journal of ophthalmology
2024

Efcab7 deletion sensitizes mice to the teratogenic effects of gastrulation-stage alcohol exposure.

Reproductive toxicology (Elmsford, N.Y.)
2024

Identification of a Novel Frameshift variant of the ATRX gene: a Case Report and Review of the genotype-phenotype relationship.

BMC pediatrics
2024

Second Case of Gonadal Mosaicism and a Novel Nonsense NR2F1 Gene Variant as the Cause of Bosch-Boonstra-Schaaf Optic Atrophy Syndrome.

Clinical genetics
2024

[Prenatal diagnosis of a fetus with 15q11q13 complex duplication syndrome and a literature review].

Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Síndrome de atrofia óptica-transtorno do desenvolvimento intelectual.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Síndrome de atrofia óptica-transtorno do desenvolvimento intelectual

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Ordenadas pelo número de sintomas em comum.

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Recessive Loss of DIAPH1 Function Causes a Progressive Neurodevelopmental Syndrome with Variable Immunological Involvement.
    Genetics in medicine : official journal of the American College of Medical Genetics· 2026· PMID 41860019mais citado
  2. Znhit3 regulates p53/p21 signaling and governs cerebellar granule cell development.
    Cell death and differentiation· 2026· PMID 41857137mais citado
  3. Clinical, Neuroimaging and Video Electroencephalography Findings in Children With Congenital Zika Syndrome: An Analysis From a Neurorehabilitation Centre.
    International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience· 2026· PMID 41839214mais citado
  4. Generation of BBSOAS patient-specific induced pluripotent stem cell lines harboring six NR2F1 pathogenic variants.
    Stem cell research· 2026· PMID 41825301mais citado
  5. Sleep-Disordered Breathing in Chung-Jansen Syndrome.
    International journal of molecular sciences· 2026· PMID 41751879mais citado
  6. Bi-allelic variants in FSD1L cause a neurodevelopmental disorder overlapping with L1 syndrome.
    Am J Hum Genet· 2026· PMID 41720098recente
  7. Bilateral Testicular Regression Syndrome and Optic Nerve Atrophy: Clinical Aspects of a Child with a SEMA3E Loss-of-Function Variant.
    Sex Dev· 2025· PMID 41243476recente
  8. Novel variant causing OTUD6B-related syndrome with ocular dysplasia and hypothyroidism: the first Chinese case.
    BMC Pediatr· 2025· PMID 41188742recente
  9. Poretti-Boltshauser Syndrome: A Potential Pathognomonic "Wolfjaw" Pattern of Retinal Perfusion.
    Ophthalmic Surg Lasers Imaging Retina· 2025· PMID 40711401recente
  10. Strabismus in Genetic Syndromes: A Review.
    Clin Exp Ophthalmol· 2025· PMID 39948700recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:401777(Orphanet)
  2. OMIM OMIM:615722(OMIM)
  3. MONDO:0014320(MONDO)
  4. GARD:12903(GARD (NIH))
  5. Variantes catalogadas(ClinVar)
  6. Busca completa no PubMed(PubMed)
  7. Q55784781(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Síndrome de atrofia óptica-transtorno do desenvolvimento intelectual
Compêndio · Raras BR

Síndrome de atrofia óptica-transtorno do desenvolvimento intelectual

ORPHA:401777 · MONDO:0014320
Prevalência
<1 / 1 000 000
Casos
6 casos conhecidos
Herança
Autosomal dominant
CID-10
H47.2 · Atrofia óptica
CID-11
Início
Neonatal
Prevalência
0.0 (Worldwide)
MedGen
UMLS
C3810363
Testes
2 disponíveis
Wikidata
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades